Loading cancer entity…
Loading cancer entity…
Clinical trials
31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04341129 | Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | completed | Early Phase 1 | 50 | University of ChicagoOTHER | 1 | Dec 5, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Dec 5, 2023source: clinicaltrials